Back
CRISPR Therapeutics AG Vs. Novartis AG Industry Stock Comparison
Buy
66
CRSP
CRISPR Therapeutics AG
Last Price:
56.19
Seasonality Move:
18.28%
Buy
64
NVS
Novartis AG
Last Price:
102.55
Seasonality Move:
1.6%
Buy
66
CRISPR Therapeutics AG (CRSP)
is a Buy
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
- The current CRISPR Therapeutics AG [CRSP] share price is $56.22. The Score for CRSP is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- CRSP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $102.57. The Score for NVS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $56.22
The current trend is relatively stagnant and CRSP is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $102.57
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVS is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.69 | Sell |
Relative Strength Index (14 RSI): | 47.02 | Sell |
Chaikin Money Flow: | 885602 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (53.68 - 56.9) | Buy |
Bollinger Bands (100): | (56.93 - 76.01) | Sell |
NVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.71 | Buy |
Relative Strength Index (14 RSI): | 69.01 | Buy |
Chaikin Money Flow: | -527043 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (94.95 - 101.37) | Buy |
Bollinger Bands (100): | (96.19 - 104.97) | Buy |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.78 | Buy |
20-day SMA: | 54.94 | Buy |
50-day SMA: | 62.33 | Sell |
200-day SMA: | 59.32 | Sell |
8-day EMA: | 55.47 | Buy |
20-day EMA: | 56.17 | Buy |
50-day EMA: | 60.58 | Sell |
200-day EMA: | 61.45 | Sell |
NVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 102 | Buy |
20-day SMA: | 99.32 | Buy |
50-day SMA: | 97.31 | Buy |
200-day SMA: | 99.54 | Buy |
8-day EMA: | 101.81 | Buy |
20-day EMA: | 99.82 | Buy |
50-day EMA: | 98.76 | Buy |
200-day EMA: | 98.63 | Buy |
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.56 per share, a decrease next quarter of $0.03 per share, a decrease this year of $2.50 per share, and an increase next year of $1.15 per share.
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.50 per share, and an increase next year of $0.74 per share.
CRISPR Therapeutics AG Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |